Abstract
Aplastic anaemia (AA) is a rare bone marrow failure syndrome treated either by immunosuppressive therapy or allogeneic stem cell transplantation (SCT). At present, no randomised clinical trials evaluating both treatment options, and in particular SCT from unrelated donors, are available. We here report the clinical course and outcome of allogeneic SCT for 20 consecutive adult patients with AA. Newly diagnosed and untreated patients (n = 8) or patients pre-treated by immunosuppressive therapy (n = 12) were transplanted either from human-leukocyte-antigen (HLA) identical family donors (n = 13) or matched (n = 6) and mismatched (n = 1) unrelated donors, respectively. Conditioning varied depending on donor type and included cyclophosphamide with or without anti-thymocyte globulin (ATG) and fludarabine–cyclophosphamide–ATG with or without low-dose total body irradiation. With a median follow-up of more than 40 months, all patients have had favourable outcomes with stable haematopoietic engraftment and high performance scores. Six patients developed acute (five I°–II°; one >II°) and four limited chronic graft-versus-host disease. In this group of AA patients, allogeneic SCT has proven very successful, independent of donor type and pre-treatment. Studies with greater cohorts of patients are warranted to better determine indication and timing of SCT especially from unrelated donors in AA.
Similar content being viewed by others
References
Young N, Calado R, Scheinberg P (2006) Current concepts in the pathophysiology and treatment of aplastic anemia. Blood 108(8):2509–2519
Marsh J, Ball S, Darbyshire P, Gordon-Smith E, Keidan A, Martin A et al. (2003) Guidelines for the diagnosis and management of acquired aplastic anaemia. Br J Haematol 123(5):782–801
Locasciulli A, Oneto R, Bacigalupo A, Socie G, Korthof E, Bekassy A et al. (2007) Outcome of patients with acquired aplastic anemia given first line bone marrow transplant or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT). Haematologica 92(1):11–8
Bai L, Chiou T, Liu JH, Yen CW, Yan M, Hsiao L et al. (2004) Hematopoietic stem cell transplantation for severe aplastic anemia—experience of an institute in Taiwan. Ann Hematol 83(1):38–43
Reiter E, Keil F, Brugger S, Kahls P, Rabitsch W, Hinterberger W et al. (1997) Excellent long-term survival after allogeneic marrow transplantation in patients with severe aplastic anemia. Bone Marrow Transplant 19(12):1191–1196
Bacigalupo A, Hows J, Gordon-Smith E, Gluckman E, Van Lint M, Congiu M et al. (1988) Bone marrow transplant for severe aplastic anemia from donors other than HLA identical siblings: a report of BMT Working Party. Bone Marrow Transplant 3(6):531–535
Hows J, Szydlo R, Anasetti C, Camitta B, Gajewski J, Gluckman E (1992) Unrelated donor marrow transplants for severe acquired aplastic anemia. Bone Marrow Transplant 10(Suppl 1):102–106
Kernan N, Bartsh G, Ash R, Beatty P, Champlin R, Filipovich A et al. (1993) Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 328(9):593–602
Margolis D, Casper J (2000) Alternative-donor hematopoietic stem-cell transplantation for severe aplastic anemia. Semin Hematol 37(1):43–55
Passweg J, Pérez W, Eapen M, Camitta B, Gluckman E, Hinterberger W et al. (2006) Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia. Bone Marrow Transplant 37(7):641–649
Maury S, Balère-Appert ML, Chir Z, Boiron JM, Galambrun C, Yakouben K et al. (2007) Unrelated stem cell transplantation for severe acquired aplastic anemia: improved outcome in the era of high-resolution HLA matching between donor and recipient. Haematologica 92(5):589–596
Horowitz M (2000) Current status of allogeneic bone marrow transplant in acquired aplastic anemia. Semin Hematol 37(1):30–42
Deeg H, Seidel K, Casper J, Anasetti C, Davies S, Gajewski J et al. (1999) Marrow transplantation from unrelated donors for patients with severe aplastic anemia who have failed immunosuppressive therapy. Biol Blood and Marrow Transplantation 5(4):243–252
Bacigalupo A, Locatelli F, Lanino E, Marsh J, Socié G, Maury S et al. (2005) Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party. Bone Marrow Transplant 36(11):947–950
Deeg H, O'Donnell M, Tolar J, Agarwal R, Harris R, Feig S et al. (2006) Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy. Blood 108:1485–1491
Storb R, Blume K, O'Donnell M, Chauncey T, Forman S, Deeg H et al. (2001) Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: the experience in four centers. Biol Blood and Marrow Transplantation 7(1):39–44
Kahl C, Leisenring W, Deeg H, Chauncey T, Flowers M, Martin P et al. (2005) Cyclophosphamide and antithymocyte globulin as a conditioning regimen for allogeneic marrow transplantation in patients with aplastic anaemia: a long-term follow-up. Br J Haematol 130(5):747–751
Kojima S, Matsuyama T, Kato S, Kigasawa H, Kobayashi R, Kikuta A et al. (2002) Outcome of 154 patients with severe aplastic anemia who received transplants from unrelated donors: the Japan Marrow Donor Program. Blood 100(3):799–803
Kennedy-Nasser AA, Leung KS, Mahajan A, Weiss HL, Arce JA, Gottschalk S et al. (2006) Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia. Biol Blood Marrow Transplant 12:1277–1284
Inamoto Y, Suzuki R, Kuwatsuka Y, Yasuda T, Takahashi T, Tsujimura A et al. (2008) Long-term outcome after Bone Marrow Transplant for aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning regimen. Biol Blood Marrow Transplant 14:43–49
Teramura M, Kimura A, Iwase S, Yonemura Y, Nakao S, Urabe A et al. (2007) Treatment of severe aplastic anemia with antithymocyte globulin and cyclosporin A with or without G-CSF in adults: a multicenter randomized study in Japan. Blood 110:1756–1761
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Buchholz, S., Dammann, E., Koenecke, C. et al. Allogeneic stem cell transplantation from related and unrelated donors for aplastic anaemia in adults—a single-centre experience. Ann Hematol 87, 551–556 (2008). https://doi.org/10.1007/s00277-008-0466-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-008-0466-z